Skip to main content
Equibles

MORGAN STANLEY

Position in LPCN — Lipocine Inc.

CIK 895421 NEW YORK, NY
Back to LPCN Full portfolio

Position in LPCN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,469
-$3,117 QoQ
Shares Held
574
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 36 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. LPCN ranks #460 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in LPCN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,469 574
2026-03-31 $4,586 574
2025-12-31 $6,030 751
2025-09-30 $1,637 575
2025-06-30 $1,816 575
2025-03-31 $8,188 2,575
2024-12-31 $12,853 2,634
2024-09-30 $11,826 2,634
2024-06-30 $21,703 2,634
2024-03-31 $3,754 722
2023-12-31 $2,014 722
2023-09-30 $2,151 722
2023-06-30 $5,780 1,147
2023-03-31 $7,466 23,481
2022-12-31 $9,345 23,482
2022-09-30 $15,990 35,537
2022-06-30 $45,646 56,987
2022-03-31 $55,926 40,823
2021-12-31 $224,210 226,248
2021-09-30 $459,127 421,218
2021-06-30 $1,091,662 779,759
2021-03-31 $45,602 30,200
2020-12-31 $37,468 27,550
2020-09-30 $7,120 5,050
2020-06-30 $1,890 1,500
2020-03-31 $720 1,500